Ben Freeberg has experience in cancer-focused venture capital, having invested in and built healthcare technology startups, including Thyme Care, and served as a cancer survivor.

start-ups transforming the future of cancer care.

Oncology Ventures invests in **Colla Health** and **Blimp Comedy**, two companies addressing behavioral health needs in oncology care. The move reflects growing recognition of mental health support as a critical component of cancer treatment. Both startups focus on integrating behavioral health services into oncology workflows, though specific details of their solutions remain undisclosed.

May 2026oncologyventures.substack.comNews article

Oncology Ventures explores overlooked strategies for accelerating innovation in oncology startups. The article highlights systemic barriers that hinder growth, such as regulatory inefficiencies and fragmented funding ecosystems. It suggests actionable levers—like cross-sector partnerships and data-sharing frameworks—to improve scalability for early-stage biotech firms.

Jun 2025oncologyventures.substack.comNews article

Oncology Ventures secures over $30 million in commitments for its first venture fund, exceeding subscription targets. The firm also announces an investment in **mPATH**, a company developing oncology-focused technologies. The fund aims to support early-stage startups in the cancer therapeutics and diagnostics space.

Aug 2024oncologyventures.substack.comNews article

Ben Freeberg, a former associate at Alpha Partners, launches **Oncology Ventures** to address gaps in cancer care after experiencing unexplained medical symptoms. His personal journey as a cancer survivor drives the venture’s mission to enhance diagnostic and treatment approaches. The initiative aims to leverage his industry experience to develop innovative solutions in oncology.

Aug 2024TechCrunchNews article